Research published in Ophthalmologica shows aflibercept “treat and extend” (TAE) protocol is efficacious in typical AMD patients.
Research, reported in EURETINA’s professional journal, Ophthalmologica, has shown that a treat-and-extend (“TAE”) regimen using aflibercept for typical AMD appears effective for improving AMD and exudative changes. In addition the investigators commented that the exudation observed in participants may be suppressed with fewer treatments in classic choroidal neovascularisation (CNV), compared to occult CNV. The research, […]Read full story
Expert research scientists in demand to support evaluation of new drug approvals for novel technologies, including retinal stem cell and gene therapies
A Nature editorial has called for increased support from research scientists into translational medicine, specifically in regards to cutting edge and novel technologies now seeking marketing approval in both the EU and USA. Citing gene therapy approaches to retinal disorders, the Nature opinion seeks to encourage specialist researchers in fields such as genetics, stem cell […]Read full story
Joint Spanish and Israeli research identifies recessive gene mutations underlying syndromic RP and intellectual disability
A joint Spanish and Israeli study, conducted by investigators from the Fundacion Jimenez Diaz University Hospital (IIS-FJD, UAM), Madrid, and the Israel Institute of Technology in Haifa, has shown that mutations in the SCAPER gene give rise to a syndromic recessive form of retinitis pigmentosa (RP) manifesting in both retinal degeneration and mental retardation. Whole […]Read full story